Association between changes in lipid profiles and progression of symptomatic intracranial atherosclerotic stenosis: A prospective multicenter study

Stroke

Volumn 43, Issue 7, 2012, Pages 1824-1830

  Kim, Dong Eog ^a   Kim, Jeong Yeon ^a   Jeong, Sang Wuk ^a   Cho, Yong Jin ^b   Park, Jong Moo ^c   Lee, Ju Hun ^d   Kang, Dong Wha ^e   Yu, Kyung Ho ^f   Bae, Hee Joon ^g   Hong, Keun Sik ^b   Koo, Ja Seong ^e   Lee, Seung Hoon ^g   Lee, Byung Chul ^f   Han, Moon Ku ^g   Rha, Joung Ho ⁱ   Lee, Yong Seok ^g   Kim, Gyeong Moon ^j   Chae, Seok Lae ^a   Kim, Jong S ^h   Kwon, Sun U ^e  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Inje University   (South Korea)

^c Eulji University   (South Korea)

^d Kangdong Sacred Heart Hospital   (South Korea)

^e Asan Medical Center   (South Korea)

^f Hallym University   (South Korea)

^g Seoul National University Hospital   (South Korea)

^h The Catholic University of Korea   (South Korea)

ⁱ Inha University Hospital   (South Korea)

^j Sungkyunkwan University   (South Korea)

more..

Author keywords

high density lipoprotein; intracranial atherosclerosis; magnetic resonance angiography; remnant lipoprotein

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BASILAR ARTERY; BRAIN ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HUMAN; INTRACRANIAL ATHEROSCLEROTIC STENOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; MULTICENTER STUDY; PRIORITY JOURNAL; STROKE;

AGED; CAROTID STENOSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84863323755     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.653659     Document Type: Article

References (28)

1. Minematsu K, Bang OY, Uehara T. Risk Factors. In: Kim JS, Caplan LR, Wong KS, eds. Intracranial Atherosclerosis. West Sussex, UK: Wiley-Blackwell; 2008:45-54.
2. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69:2063-2068. (Pubitemid 350175708)
3. Park JH, Hong KS, Lee EJ, Lee J, Kim DE. High levels of apolipoprotein B/AI ratio are associated with intracranial atherosclerotic stenosis. Stroke. 2011;42:3040-3046.
4. Devaraj S, Vega G, Lange R, Grundy SM, Jialal I. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. Am J Med. 1998;104:445-450. (Pubitemid 28274848)
5. Hodis HN. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation. 1999;99:2852-2854. (Pubitemid 29258969)
6. Jialal I, Devaraj S. Remnant lipoproteins: measurement and clinical significance. Clin Chem. 2002;48:217-219. (Pubitemid 34107258)
7. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 1999;99:2858-2860. (Pubitemid 29258971)
8. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis. 2001;154:229-236. (Pubitemid 32010711)
9. Tanaka A. Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb. 2004;11:322-329.
10. Nakamura T, Obata JE, Takano H, Kawabata K, Sano K, Kobayashi T, et al. High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis. Atherosclerosis. 2009;202:234-240.
11. Kim JY, Park JH, Jeong SW, Schellingerhout D, Park JE, Lee DK, et al. High levels of remnant lipoprotein cholesterol is a risk factor for large artery atherosclerotic stroke. J Clin Neurol. 2011;7:203-209.
12. Kwon SU, Hong KS, Kang DW, Park JM, Lee JH, Cho YJ, et al. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke. 2011;42:2883-2890.
13. Leary ET, Wang T, Baker DJ, Cilla DD, Zhong J, Warnick GR, et al. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin Chem. 1998;44:2490-2498. (Pubitemid 28565661)
14. Moore KJ, Rayner K. Macrophage foam cell formation: the pathways to cholesterol engorgement. In: George SJ, Johnson J, eds. Atherosclerosis Molecular and Cellular Mechanisms. Weinheim, Germany: Wiley-Blackwell; 2010:229-254.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
16. Karpe F, Taskinen MR, Nieminen MS, Frick MH, Kesaniemi YA, Pasternack A, et al. Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment. Atherosclerosis. 2001;157:181-187. (Pubitemid 32539369)
17. Doi H, Kugiyama K, Oka H, Sugiyama S, Ogata N, Koide SI, et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation. 2000;102: 670-676. (Pubitemid 30640668)
18. Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T, et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol. 2004;43:2219-2224. (Pubitemid 38757588)
19. Griendling KK, Alexander RW. Endothelial control of the cardiovascular system: recent advances. FASEB J. 1996;10:283-292. (Pubitemid 26079947)
20. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation. 1998;97:2519-2526. (Pubitemid 28294498)
21. Chen A, Shyr MH, Chen TY, Lai HY, Lin CC, Yen PS. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease. AJNR Am J Neuroradiol. 2006;27:1876-1881. (Pubitemid 44556502)
22. Ma J, Mehrkens JH, Holtmannspoetter M, Linke R, Schmid-Elsaesser R, Steiger HJ, et al. Perfusion MRI before and after acetazolamide administration for assessment of cerebrovascular reserve capacity in patients with symptomatic internal carotid artery (ICA) occlusion: comparison with 99MTC-ECD SPECT. Neuroradiology. 2007;49:317-326. (Pubitemid 46510886)
23. Miyazawa N, Akiyama I, Yamagata Z. Analysis of incidence and risk factors for progression in patients with intracranial steno-occlusive lesions by serial magnetic resonance angiography. Clin Neurol Neurosurg. 2007;109:680-685. (Pubitemid 47260653)
24. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004;292:2217-2225.
25. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022-2031. (Pubitemid 38781102)
26. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
27. Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, Wu P, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009;338:b92.
28. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373-1379. (Pubitemid 27028925)